BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2371306)

  • 1. Evaluation of the bioluminescence assays as screens for genotoxic chemicals.
    Elmore E; Fitzgerald MP
    Prog Clin Biol Res; 1990; 340D():379-87. PubMed ID: 2371306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of genotoxicity of metallic compounds by the bacterial bioluminescence test.
    Ulitzur S; Barak M
    J Biolumin Chemilumin; 1988; 2(2):95-9. PubMed ID: 3213595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term tests for defining mutagenic carcinogens.
    Waters MD; Stack HF; Jackson MA
    IARC Sci Publ; 1999; (146):499-536. PubMed ID: 10353401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenesis, clastogenesis, carcinogenesis: expectations, correlations and relations.
    Zeiger E; Tennant RW
    Prog Clin Biol Res; 1986; 209B():75-84. PubMed ID: 3529117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutatox: a genotoxicity assay using luminescent bacteria.
    Bulich A
    Schriftenr Ver Wasser Boden Lufthyg; 1992; 89():763-70. PubMed ID: 1307839
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro testing for carcinogens and mutagens.
    Santella RM
    Occup Med; 1987; 2(1):39-46. PubMed ID: 3306977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which rules for assembling short-term test batteries to predict carcinogenicity?
    Benigni R; Giuliani A
    Mol Toxicol; 1987; 1(2-3):143-66. PubMed ID: 3449755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformed roots of Crepis capillaris--a [corrected] sensitive system for the evaluation of the clastogenicity of abiotic agents.
    Juchimiuk J; Maluszynska J
    Mutat Res; 2005 Jan; 565(2):129-38. PubMed ID: 15661611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens.
    Natarajan AT; Darroudi F
    Mutagenesis; 1991 Sep; 6(5):399-403. PubMed ID: 1665540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotoxic and mutagenic studies of teratogens in developing rat and mouse.
    Rencüzoğulları E; Aydın M
    Drug Chem Toxicol; 2019 Jul; 42(4):409-429. PubMed ID: 29745766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term tests, genotoxicity and carcinogenicity in light of a multivariate statistical exploration.
    Benigni R
    Ann Ist Super Sanita; 1989; 25(4):573-5. PubMed ID: 2631623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for the identification of rodent carcinogens by in vitro short-term tests.
    Zeiger E
    Prog Clin Biol Res; 1990; 340D():261-71. PubMed ID: 2371299
    [No Abstract]   [Full Text] [Related]  

  • 17. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the mode of action framework for mutagenic carcinogens case study: Cyclophosphamide.
    McCarroll N; Keshava N; Cimino M; Chu M; Dearfield K; Keshava C; Kligerman A; Owen R; Protzel A; Putzrath R; Schoeny R
    Environ Mol Mutagen; 2008 Mar; 49(2):117-31. PubMed ID: 18240158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic activity of diesel emissions.
    Lewtas J
    Dev Toxicol Environ Sci; 1982; 10():243-64. PubMed ID: 6176425
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagenicity assessment of acrylate and methacrylate compounds and implications for regulatory toxicology requirements.
    Johannsen FR; Vogt B; Waite M; Deskin R
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):322-35. PubMed ID: 18346829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.